English
|
Español
English
|
Español
Insurance
Marketing
Pharmaceuticals
Technology/Innovation
Regulatory
Community
Daiichi Sankyo
Press release submission
| Jun 28, 2020
DAIICHI SANKYO: Provides Update on CHMP Review of Pexidartinib, a CSF1R Inhibitor for the Treatment of Patients with TGCT
Trending
+
Marketing
Patient Daily
| Mar 14, 2025
Founder of Medfluence Advisors on healthcare marketing: 'The patient journey is more complex than ever'
+
Community
Patient Daily
| Mar 14, 2025
Doctor on weather-related pressure headaches: This could happen 'if you have an underlying chronic sinus disease'
C.D. Marsden
| Mar 14, 2025
Solidarity Health to Musk, RFK, Jr: ‘Enforce the CMS Hospital Price Transparency Rule’
